Seroprevalence of pertussis amongst healthcare professionals in Spain

Vaccine

Volumn 34, Issue 8, 2016, Pages 1109-1114

  Rodríguez de la Pinta, María Luisa ^a   Castro Lareo, María Isabel ^b   Ramon Torrell, Josep Maria ^c   García de Lomas, Juan ^d,e   Devadiga, Raghavendra ^f   Reyes, Janet ^g   McCoig, Cynthia ^g   Tafalla, Monica ^h   García Corbeira, Pilar ^g  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b Instituto de Investigación Biomédica   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d UNIVERSITY OF VALENCIA   (Spain)

^e Instituto Valenciano de Microbiologia   (Spain)

^f GlaxoSmithKline Pharmaceuticals Ltd   (India)

^g GSK   (Spain)

^h GSK   (Belgium)

Author keywords

Healthcare professionals; Pertussis antibodies; Seroprevalence

Indexed keywords

PERTUSSIS VACCINE; BACTERIUM ANTIBODY;

ADULT; ARTICLE; BLOOD SAMPLING; ENZYME LINKED IMMUNOSORBENT ASSAY; FATALITY; FEMALE; HEALTH CARE PERSONNEL; HIGH RISK POPULATION; HOSPITAL DEPARTMENT; HOUSEHOLD; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDWIFE; MULTICENTER STUDY; NURSE; PERTUSSIS; PHYSICIAN; PRIORITY JOURNAL; SEROPREVALENCE; SPAIN; VACCINATION; YOUNG ADULT; AGED; BLOOD; CLINICAL TRIAL; EPIDEMIOLOGY; HOSPITAL; HOSPITAL PERSONNEL; MIDDLE AGED; PREVALENCE; WHOOPING COUGH;

ADULT; AGED; ANTIBODIES, BACTERIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITALS; HUMANS; MALE; MIDDLE AGED; PERSONNEL, HOSPITAL; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES; SPAIN; WHOOPING COUGH; YOUNG ADULT;

EID: 84955262962     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.12.036     Document Type: Article

References (34)

1. Black R.E., Cousens S., Johnson H.L., Lawn J.E., Rudan I., Bassani D.G., et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 2010, 375(9730):1969-1987. 10.1016/S0140-6736(10)60549-1.
2. Pertussis (Whooping Cough). Centers for Disease Control and Prevention. Available from: [accessed on 07.07.15]. http://www.cdc.gov/pertussis/countries.html.
3. Centro Nacional de Epidemiología. Instituto de Salud Carlos III. Ministerio de Sanidad y Consumo. Cobertura vacunal 1997. Bol Epidemiol Sem 1998, 6:197-208.
4. Situación de la tos ferina en España. Red Nacional de Vigilancia Epidemiológica de España. Año 2009. Centro Nacional de Epidemiología. Instituto de Salud Carlos III. Available from: [accessed on 12.02.14]. http://www.isciii.es/ISCIII/es/contenidos/fd-servicios-cientifico-tecnicos/fd-vigilancias-alertas/fd-enfermedades/Informetosferinajunio2009.pdf.
5. Red Nacional de Vigilancia Epidemiológica. Instituto de Salud Carlos III. Boletín Epidemiológico Semanal en Red. Informe Semanal relativo a las Enfermedades de Declaración Obligatoria. España. Boletín Epidemiológico Semanal en Red. 23 de enero de 2012. Available from: [accessed on 12.02.14]. http://www.isciii.es/ISCIII/es/contenidos/fd-servicios-cientifico-tecnicos/fd-vigilancias-alertas/fd-boletines/fd-boletin-epidemiologico-semanal-red/pdf_2012/IS-120123-WEB.pdf.
6. Campins M., Moreno-Pérez D., Gil-de Miguel A., González-Romo F., Moraga-Llop F.A., Arístegui-Fernández J., et al. Whooping cough in Spain, Current epidemiology, prevention and control strategies. Recommendations by the Pertussis Working Group. Enferm Infecc Microbiol Clin 2013, 31(4):240-253. 10.1016/j.eimc.2012.12.011.
7. Hoffait M., Hanlon D., Benninghoff B., Calcoen S. Pertussis knowledge, attitude and practices among European health care professionals in charge of adult vaccination. Human Vaccin 2011, 7(2):197-201.
8. Koepke R., Eickhoff J.C., Ayele R.A., Petit A.B., Schauer S.L., Hopfensperger D.J., et al. Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine (Tdap) for preventing pertussis: evidence of rapidly waning immunity and difference in effectiveness by Tdap brand. J Infect Dis 2014, 210(6):942-953. 10.1093/infdis/jiu322.
9. Zepp P., Heininger U., Mertsola J., Bernatowska E., Guiso N., Roord J., et al. Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis 2011, 11(7):557-570. 10.1016/S1473-3099(11)70007-X.
10. Cherry J.D. The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection. Pediatrics 2005, 115(5):1422-1427.
11. Christie C.D., Glover A.M., Willke M.J., Marx M.L., Reising S.F., Hutchinson N.M. Containment of pertussis in the regional pediatric hospital during the Greater Cincinnati epidemic of 1993. Infect Control Hosp Epidemiol 1995, 16(10):556-563.
12. Kurt T.L., Yeager A.S., Guenette S., Dunlop S. Spread of pertussis by hospital staff. J Am Med Assoc 1972, 221(3):264-267.
13. Linnemann C.C., Ramundo N., Perlstein P.H., Minton S.D., Englender G.S. Use of pertussis vaccine in an epidemic involving hospital staff. Lancet 1975, 20(2):540-543.
14. Valenti W.M., Pincus P.H., Messner M.K. Nosocomial pertussis: possible spread by a hospital visitor. Am J Dis Child 1980, 134(5):520-521.
15. Langkamp D.L., Davis J.P. Increased risk of reported pertussis and hospitalization associated with pertussis in low birth weight children. J Pediatr 1996, 128(5 Pt 1):654-659.
16. Ministerio de Sanidad y Consumo Vacuna de tos ferina. Vacunación en Adultos, Recomendaciones Año 2004 2004, 17-22. Ministerio de Sanidad y Consumo, Madrid, Available from: https://www.msssi.gob.es/ciudadanos/proteccionSalud/vacunaciones/docs/recoVacunasAdultos.pdf [accessed on 15.11.14].
17. Grupo de trabajo tos ferina 2012 de la Ponencia de Programa y Registro de Vacunaciones. Revisión del programa de vacunación frente a tos ferina en España. Comisión de Salud Pública del Consejo Interterritorial del Sistema Nacional de Salud. Ministerio de Sanidad, Servicios Sociales e Igualdad, 2013. Available from: [accessed on 15.11.14]. https://www.msssi.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/docs/TosFerina.pdf.
18. Advisory Committee on Immunization Practices; Centers for Disease Control and Prevention (CDC) Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011, 60(RR-7):1-45.
19. Urbiztondo L., Broner S., Costa J., Rocamora L., Bayas J.M., Campins M., et al. Seroprevalence study of B. pertussis infection in health care workers in Catalonia, Spain. Hum Vaccin Immunother 2015, 11(1):293-297. 10.4161/hv.36167.
20. PERTUSSCAN PT IgG, PERT-PTG2 Product Sheet. Euro Diagnostica AB. Available from: [accessed on 24.11.15]. http://www.eurodiagnostica.com/index.php?headId=3%26pageId=3%26productId=90.
21. de Juanes J.R., Gil A., González A., Arrazola M.P., San-Martín M., Esteban J. Seroprevalence of pertussis antibody among health care personnel in Spain. Eur J Epidemiol 2004, 19(1):69-72.
22. Ortega P., Gil A., Astasio P., Domínguez V., De Juanes J.R., Arrazola P., et al. Prevalence of antibodies against tetanus, diphteria and Bordetella pertussis in health care professionals. Enferm Infecc Microbiol Clin 1999, 17(3):135-137.
23. García-Corbeira P., Dal-Ré R., Aguilar L., García-de-Lomas J. Seroepidemiology of Bordetella pertussis infections in the Spanish population: a cross-sectional study. Vaccine 2000, 18(21):2173-2176.
24. Domínguez A., Vidal J., Plans P., Salleras L. The seroepidemiology of B. pertussis infection in Catalonia, Spain. Epidemiol Infect 2001, 126(2):205-210.
25. Higa F., Haranaga S., Tateyama M., Hibiya K., Yamashiro T., Nakamatsu M., et al. Assessment of serum anti-Bordetella pertussis antibody titers among medical staff members. Jpn J Infect Dis 2008, 61(5):371-374.
26. Hashemi S.H., Ranjbar M., Hajilooi M., Seif-Rabiei M.A., Bolandi M., Moghimi J. Seroprevalence of Immunoglobulin G antibodies against pertussis toxin among asymptomatic medical students in the west of Iran: a cross sectional study. BMC Infect Dis 2009, 9:58. 10.1186/1471-2334-9-58.
27. Ward A., Caro J., Bassinet L., Housset B., O'Brien J.A., Guiso N. Health and economic consequences of an outbreak of pertussis among healthcare workers in a hospital in France. Infect Control Hosp Epidemiol 2005, 26(3):288-292.
28. Kuncio D.E., Middleton M., Cooney M.G., Ramos M., Coffin S.E., Feemster K.A. Health care worker exposures to pertussis: missed opportunities for prevention. Pediatrics 2014, 133(1):15-21. 10.1542/peds.2013-0745.
29. Calugar A., Ortega-Sánchez I.R., Tiwari T., Oakes L., Jahre J.A., Murphy T.V. Nosocomial pertussis: costs of an outbreak and benefits of vaccinating health care workers. Clin Infect Dis 2006, 42(7):981-988.
30. Salgado C.S., Giannetta E.T., Hayden F.G., Farr B.M. Preventing nosocomial influenza by improving the vaccine acceptance rate of clinicians. Infect Control Hosp Epidemiol 2004, 25(11):923-928.
31. Recommended Vaccines for Healthcare Workers. Centers for Disease Control and Prevention. Available from: [accessed 04.1114]. http://www.cdc.gov/vaccines/adults/rec-vac/hcw.html.
32. Public Health Agency of Canada. Canadian Immunization Guide. Part 3: Vaccination of Specific Populations. Available from: [accessed 04.11.14]. http://www.phac-aspc.gc.ca/publicat/cig-gci/p03-work-travail-eng.php.
33. Maltezou H.C., Wicker S., Borg M., Heininger U., Puro V., Theodoridou M., et al. Vaccination policies for health-care workers in acute health-care facilities in Europe. Vaccine 2011, 29(51):9557-9562. 10.1016/j.vaccine.2011.09.076.
34. Top K.A., Halperin B.A., Baxendale D., MacKinnon-Cameron D., Halperin S.A. Pertussis immunization in pediatric healthcare workers: knowledge, attitudes, beliefs, and behaviour. Vaccine 2010, 28(10):2169-2173. 10.1016/j.vaccine.2009.12.060.